Core Viewpoint - Concentra Group reported quarterly earnings of $0.28 per share, exceeding the Zacks Consensus Estimate of $0.23 per share, and showing an increase from $0.17 per share a year ago, indicating a positive earnings surprise of +21.74% [1] Financial Performance - The company achieved revenues of $539.08 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.29% and up from $465.04 million year-over-year [2] - Over the last four quarters, Concentra has exceeded consensus EPS estimates three times and topped revenue estimates four times [2] Stock Performance - Concentra shares have increased approximately 18.9% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.5% [3] Future Outlook - The company's earnings outlook will be crucial for assessing future stock performance, with current consensus EPS estimates at $0.36 for the coming quarter and $1.47 for the current fiscal year [7] - The Zacks Rank for Concentra is currently 4 (Sell), indicating expectations of underperformance in the near future due to unfavorable estimate revisions prior to the earnings release [6] Industry Context - The Medical Services industry, to which Concentra belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, suggesting potential challenges ahead [8]
Concentra Group (CON) Q4 Earnings and Revenues Top Estimates